BLCO.TO BAUSCH LOMB CORPORATION
$23.86▼ -2.05%
Healthcare
Other
Volume 2.0K
Avg Volume (10D) 1.6K
Key Metrics & Fundamentals
Market Cap
$8.52B
P/E Ratio
–
Div Yield
–%
52W Range
19.36 - 25.70
% vs 50 MA
3.25%
% vs 200 MA
6.25%
RSI-14
55.4
MACD Histogram
+0.0100
Beta (1Y vs SPY)
0.79
Free Cash Flow
$82.00M
Gross Rev
$1.39B
Gross Profit
$867.00M
EBITDA
$209.00M
COGS
$527.00M
Operating Exp
$759.00M
Operating Income
$108.00M
EBIT
$108.00M
Pretax Income
-$11.00M
Net Income
-$14.00M
EPS (Diluted)
-0.04
Price & Volume History
Loading chart…
Recent News
Bausch + Lomb's SeeLyra Femtosecond Laser Gets European CE Mark Approval
MT Newswires · Sep 11, 2026 10:44 AM

Bausch + Lomb Announces European CE Mark Approval of SeeLyra™ Femtosecond Laser
Business Wire · Sep 11, 2026 10:11 AM

1 Cash-Producing Stock with Exciting Potential and 2 We Ignore
StockStory · Sep 9, 2026 1:30 PM

Bausch + Lomb Announces New Published Research on enVista Aspire™ Real World Experience
Business Wire · Sep 2, 2026 11:00 AM

Most Women Don't Recognize Dry Eye as a Symptom of Perimenopause and Menopause, New Bausch + Lomb Survey Finds
Business Wire · Sep 1, 2026 10:58 AM

Bausch + Lomb (BLCO) Stock Trades Below Fair Value As Caution Lingers
Simply Wall St. · Aug 29, 2026 11:06 PM

1 Unpopular Stock That Deserves a Second Chance and 2 We Turn Down
StockStory · Aug 28, 2026 11:12 AM

3 Healthcare Stocks We Steer Clear Of
StockStory · Aug 27, 2026 2:33 PM
Zepbound may cut healthcare costs, study says; Summit, Akeso drug hits in another China trial
BioPharma Dive · Aug 26, 2026 10:11 AM

A Look Back at Medical Devices & Supplies - Specialty Stocks’ Q2 Earnings: Bausch + Lomb (NYSE:BLCO) Vs The Rest Of The Pack
StockStory · Aug 25, 2026 4:54 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See BLCO.TO's money flow as a full page
Social Sentiment
No Reddit posts found for BLCO.TO.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.